Cite
Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients.
MLA
Lamy, Gaspard, et al. “Heterogeneous Neutralizing Antibodies Production after SARS-CoV-2 Vaccination in Haemodialysis Patients.” Clinical Kidney Journal, vol. 14, no. 12, Sept. 2021, pp. 2616–17. EBSCOhost, https://doi.org/10.1093/ckj/sfab171.
APA
Lamy, G., Vauloup Fellous, C., Mouna, L., Dargelos, M., Vilaine, E., Couturier, A., Chhom, P., Essig, M., & Massy, Z. A. (2021). Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients. Clinical Kidney Journal, 14(12), 2616–2617. https://doi.org/10.1093/ckj/sfab171
Chicago
Lamy, Gaspard, Christelle Vauloup Fellous, Lina Mouna, Mathilde Dargelos, Eve Vilaine, Aymeric Couturier, Panha Chhom, Marie Essig, and Ziad A Massy. 2021. “Heterogeneous Neutralizing Antibodies Production after SARS-CoV-2 Vaccination in Haemodialysis Patients.” Clinical Kidney Journal 14 (12): 2616–17. doi:10.1093/ckj/sfab171.